Found: 6
Select item for more details and to access through your institution.
DNase analysed by a novel competitive assay in patients with complications after ChAdOx1 nCoV‐19 vaccination and in normal unvaccinated blood donors.
- Published in:
- Scandinavian Journal of Immunology, 2023, v. 98, n. 1, p. 1, doi. 10.1111/sji.13274
- By:
- Publication type:
- Article
Elevated NETs and Calprotectin Levels after ChAdOx1 nCoV-19 Vaccination Correlate with the Severity of Side Effects.
- Published in:
- Vaccines, 2022, v. 10, n. 8, p. 1267, doi. 10.3390/vaccines10081267
- By:
- Publication type:
- Article
Vaccine Induced Immune Thrombotic Thrombocytopenia Causing a Severe Form of Cerebral Venous Thrombosis With High Fatality Rate: A Case Series.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.721146
- By:
- Publication type:
- Article
Investigation of the Optimal Dose aPCC in Reversing the Effect of Factor Xa Inhibitors—An In Vitro Study.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2021, v. 27, p. 1, doi. 10.1177/10760296211021156
- By:
- Publication type:
- Article
Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: a case series.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor.
- Published in:
- Thrombosis Journal, 2017, v. 15, p. 1, doi. 10.1186/s12959-017-0129-1
- By:
- Publication type:
- Article